Early Relapse in Multiple Myeloma: Modern Management Strategies

Early Relapse in Multiple Myeloma: Modern Management Strategies is organized by Global Oncology Academy (GOA).

Publication Dates
Release Date: 08/25/2023
Expiration Date: 08/25/2024

Description:
Recognizing and treating early relapse of multiple myeloma (MM) is a challenge for healthcare professionals. This program is designed to improve clinicians’ ability to distinguish between relapse and progression of disease in MM. In addition, the program compares the efficacy and safety of carfilzomib- and pomalidomide-based regimens in the treatment of relapsed MM, applies current and emerging treatment approaches to MM patients in early relapse, and reviews common adverse events that occur when using combination regimens to treat early relapsed myeloma.

Learning Objectives:
After participating in this educational activity, participants should be better able to:
• Distinguish between relapse and progression of disease in multiple myeloma
• Compare the efficacy and safety of carfilzomib- and pomalidomide-based regimens in the treatment of relapsed multiple myeloma
• Apply current and emerging treatment approaches to multiple myeloma patients in early relapse
• Recognize common adverse events seen with combination regimens used to treat early relapsed multiple myeloma